292 related articles for article (PubMed ID: 30338715)
21. Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia.
Briot T; Roger E; Lautram N; Verger A; Clavreul A; Lagarce F
Int J Nanomedicine; 2017; 12():8427-8442. PubMed ID: 29200853
[TBL] [Abstract][Full Text] [Related]
22. Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.
Lollo G; Vincent M; Ullio-Gamboa G; Lemaire L; Franconi F; Couez D; Benoit JP
Int J Pharm; 2015 Nov; 495(2):972-80. PubMed ID: 26428632
[TBL] [Abstract][Full Text] [Related]
23. Inter-nanocarrier and nanocarrier-to-cell transfer assays demonstrate the risk of an immediate unloading of dye from labeled lipid nanocapsules.
Simonsson C; Bastiat G; Pitorre M; Klymchenko AS; Béjaud J; Mély Y; Benoit JP
Eur J Pharm Biopharm; 2016 Jan; 98():47-56. PubMed ID: 26522878
[TBL] [Abstract][Full Text] [Related]
24. Intracellular availability of poorly soluble drugs from lipid nanocapsules.
Bohley M; Haunberger A; Goepferich AM
Eur J Pharm Biopharm; 2019 Jun; 139():23-32. PubMed ID: 30851353
[TBL] [Abstract][Full Text] [Related]
25. Toxicological study and efficacy of blank and paclitaxel-loaded lipid nanocapsules after i.v. administration in mice.
Hureaux J; Lagarce F; Gagnadoux F; Rousselet MC; Moal V; Urban T; Benoit JP
Pharm Res; 2010 Mar; 27(3):421-30. PubMed ID: 20054705
[TBL] [Abstract][Full Text] [Related]
26. Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma.
Huynh NT; Passirani C; Allard-Vannier E; Lemaire L; Roux J; Garcion E; Vessieres A; Benoit JP
Int J Pharm; 2012 Feb; 423(1):55-62. PubMed ID: 21536115
[TBL] [Abstract][Full Text] [Related]
27. Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration.
Roger E; Lagarce F; Benoit JP
Eur J Pharm Biopharm; 2011 Sep; 79(1):181-8. PubMed ID: 21303693
[TBL] [Abstract][Full Text] [Related]
28. Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy.
Jo Y; Kim EH; Sai S; Kim JS; Cho JM; Kim H; Baek JH; Kim JY; Hwang SG; Yoon M
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30469352
[TBL] [Abstract][Full Text] [Related]
29. Thymoquinone-loaded lipid nanocapsules with promising anticancer activity for colorectal cancer.
Selmi M; Salek A; Barboura M; Njim L; Trabelsi A; Lahmar A; Lautram N; Roger E; Baati T; Ghedira LC
Nanoscale Adv; 2023 Sep; 5(19):5390-5398. PubMed ID: 37767034
[TBL] [Abstract][Full Text] [Related]
30. Lipid nanocapsules as in vivo oxygen sensors using magnetic resonance imaging.
Nel J; Franconi F; Joudiou N; Saulnier P; Gallez B; Lemaire L
Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():396-403. PubMed ID: 31029333
[TBL] [Abstract][Full Text] [Related]
31. Local delivery of ferrociphenol lipid nanocapsules followed by external radiotherapy as a synergistic treatment against intracranial 9L glioma xenograft.
Allard E; Jarnet D; Vessières A; Vinchon-Petit S; Jaouen G; Benoit JP; Passirani C
Pharm Res; 2010 Jan; 27(1):56-64. PubMed ID: 19908129
[TBL] [Abstract][Full Text] [Related]
32. Locoregional Confinement and Major Clinical Benefit of
Séhédic D; Chourpa I; Tétaud C; Griveau A; Loussouarn C; Avril S; Legendre C; Lepareur N; Wion D; Hindré F; Davodeau F; Garcion E
Theranostics; 2017; 7(18):4517-4536. PubMed ID: 29158842
[TBL] [Abstract][Full Text] [Related]
33. Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma.
Bastiancich C; Vanvarenberg K; Ucakar B; Pitorre M; Bastiat G; Lagarce F; Préat V; Danhier F
J Control Release; 2016 Mar; 225():283-93. PubMed ID: 26829100
[TBL] [Abstract][Full Text] [Related]
34. Lipid-core nanocapsules are an alternative to the pulmonary delivery and to increase the stability of statins.
Lorenzoni R; Cordenonsi LM; Davies S; Antonow MB; Medina Diedrich AS; Santos CG; Vitalis GS; Garrastazu G; Buttini F; Sonvico F; Gomes P; Raffin RP
J Microencapsul; 2019 Jun; 36(4):317-326. PubMed ID: 31159613
[No Abstract] [Full Text] [Related]
35. Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications.
Formica ML; Ullio Gamboa GV; Tártara LI; Luna JD; Benoit JP; Palma SD
Int J Pharm; 2020 Jan; 573():118795. PubMed ID: 31682964
[TBL] [Abstract][Full Text] [Related]
36. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
37. Intranasal lipid nanocapsules for systemic delivery of nimodipine into the brain: In vitro optimization and in vivo pharmacokinetic study.
Mohsen K; Azzazy HME; Allam NK; Basalious EB
Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111236. PubMed ID: 32806316
[TBL] [Abstract][Full Text] [Related]
38. Lipid nanocapsules as a new delivery system in copepods: Toxicity studies and optical imaging.
Stancheva S; Souissi A; Ibrahim A; Barras A; Spriet C; Souissi S; Boukherroub R
Colloids Surf B Biointerfaces; 2015 Nov; 135():441-447. PubMed ID: 26280818
[TBL] [Abstract][Full Text] [Related]
39. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
Roger E; Lagarce F; Garcion E; Benoit JP
J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
[TBL] [Abstract][Full Text] [Related]
40. Combinational drug-loaded lipid nanocapsules for the treatment of cancer.
Tsakiris N; Papavasileiou M; Bozzato E; Lopes A; Vigneron AM; Préat V
Int J Pharm; 2019 Oct; 569():118588. PubMed ID: 31377406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
